S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats

Endogenous and exogenously administered S-nitrosothiols modulate the activities of central and peripheral systems that control breathing. We have unpublished data showing that the deleterious effects of morphine on arterial blood-gas chemistry (i.e., pH, pCO2, pO2, and sO2) and Alveolar-arterial gradient (i.e., index of gas exchange) were markedly diminished in anesthetized Sprague Dawley rats that received a continuous intravenous infusion of the endogenous S-nitrosothiol, S-nitroso-L-cysteine. The present study extends these findings by showing that unanesthetized adult male Sprague Dawley rats receiving an intravenous infusion of S-nitroso-L-cysteine (100 or 200 nmol/kg/min) markedly diminished the ability of intravenous injections of the potent synthetic opioid, fentanyl (10, 25, and 50 μg/kg), to depress the frequency of breathing, tidal volume, and minute ventilation. Our study also found that the ability of intravenously injected fentanyl (10, 25, and 50 μg/kg) to disturb eupneic breathing, which was measured as a marked increase of the non-eupneic breathing index, was substantially reduced in unanesthetized rats receiving intravenous infusions of S-nitroso-L-cysteine (100 or 200 nmol/kg/min). In contrast, the deleterious effects of fentanyl (10, 25, and 50 μg/kg) on frequency of breathing, tidal volume, minute ventilation and non-eupneic breathing index were fully expressed in rats receiving continuous infusions (200 nmol/kg/min) of the parent amino acid, L-cysteine, or the D-isomer, namely, S-nitroso-D-cysteine. In addition, the antinociceptive actions of the above doses of fentanyl as monitored by the tail-flick latency assay, were enhanced by S-nitroso-L-cysteine, but not L-cysteine or S-nitroso-D-cysteine. Taken together, these findings add to existing knowledge that S-nitroso-L-cysteine stereoselectively modulates the detrimental effects of opioids on breathing, and opens the door for mechanistic studies designed to establish whether the pharmacological actions of S-nitroso-L-cysteine involve signaling processes that include 1) the activation of plasma membrane ion channels and receptors, 2) selective intracellular entry of S-nitroso-L-cysteine, and/or 3) S-nitrosylation events. Whether alterations in the bioavailability and bioactivity of endogenous S-nitroso-L-cysteine is a key factor in determining the potency/efficacy of fentanyl on breathing is an intriguing question.

[1]  A. Grossfield,et al.  Nitrosyl factors play a vital role in the ventilatory depressant effects of fentanyl in unanesthetized rats. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  S. Perrine,et al.  Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats. , 2021, Drug and alcohol dependence.

[3]  Stephen J. Lewis,et al.  Tempol Reverses the Negative Effects of Morphine on Arterial Blood-Gas Chemistry and Tissue Oxygen Saturation in Freely-Moving Rats , 2021, Frontiers in Pharmacology.

[4]  S. Lewis,et al.  Short-term facilitation of breathing upon cessation of hypoxic challenge is impaired in male but not female endothelial NOS knock-out mice , 2021, Scientific Reports.

[5]  M. Jenkins,et al.  Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl , 2021, Frontiers in Pharmacology.

[6]  J. Bateman,et al.  Understanding and countering opioid‐induced respiratory depression , 2021, British journal of pharmacology.

[7]  Christopher G. Wilson,et al.  d-Cystine di(m)ethyl ester reverses the deleterious effects of morphine on ventilation and arterial blood gas chemistry while promoting antinociception , 2021, Scientific Reports.

[8]  Adrienn G. Varga,et al.  Neuronal Mechanisms Underlying Opioid Induced Respiratory Depression: Our Current Understanding. , 2021, Journal of neurophysiology.

[9]  Michael W. Jenkins,et al.  Glutathione ethyl ester reverses the deleterious effects of fentanyl on ventilation and arterial blood-gas chemistry while prolonging fentanyl-induced analgesia , 2021, Scientific Reports.

[10]  W. Koch,et al.  Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets , 2021, International journal of molecular sciences.

[11]  Lynn R. Webster, MD,et al.  Atypical opioids and their effect on respiratory drive. , 2021, Journal of opioid management.

[12]  S. Lewis,et al.  The Role of Carotid Sinus Nerve Input in the Hypoxic-Hypercapnic Ventilatory Response in Juvenile Rats , 2020, Frontiers in Physiology.

[13]  Michael W. Jenkins,et al.  NADPH diaphorase detects S-nitrosylated proteins in aldehyde-treated biological tissues , 2020, Scientific Reports.

[14]  R. Cariño-Cortés,et al.  Participation of the opioid receptor - nitric oxide - cGMP - K+ channel pathway in the peripheral antinociceptive effect of nalbuphine and buprenorphine in rats. , 2020, Canadian journal of physiology and pharmacology.

[15]  Kellen E. McGee,et al.  Voltage-gated potassium channel proteins and stereoselective S-nitroso-l-cysteine signaling , 2020, JCI insight.

[16]  K. Lutfy Opioid Crisis—An Emphasis on Fentanyl Analogs , 2020, Brain sciences.

[17]  A. Mori,et al.  Involvement of Gi protein–dependent BKCa channel activation in β2-adrenoceptor-mediated dilation of retinal arterioles in rats , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  John T. Williams,et al.  Recent Progress in Opioid Research from an Electrophysiological Perspective , 2020, Molecular Pharmacology.

[19]  N. Mellen,et al.  Evidence for the emergence of an opioid‐resistant respiratory rhythm following fentanyl overdose , 2020, Respiratory Physiology & Neurobiology.

[20]  B. Gaston,et al.  An Update on Thiol Signaling: S-Nitrosothiols, Hydrogen Sulfide and a Putative Role for Thionitrous Acid , 2020, Antioxidants.

[21]  F. Cunha,et al.  Peripheral nitric oxide signaling directly blocks inflammatory pain. , 2020, Biochemical pharmacology.

[22]  Mark J. Kohr,et al.  An emerging perspective on sex differences: Intersecting S-nitrosothiol and aldehyde signaling in the heart , 2020, Redox biology.

[23]  E. Levitt,et al.  Kölliker-Fuse/Parabrachial complex mu opioid receptors contribute to fentanyl-induced apnea and respiratory rate depression , 2020, Respiratory Physiology & Neurobiology.

[24]  P. Coyne,et al.  Nebulized Fentanyl for Dyspnea: A Retrospective Chart Review , 2020, Journal of pain & palliative care pharmacotherapy.

[25]  D. Atanasova,et al.  Histochemical and immunohistochemical localization of nitrergic structures in the carotid body of spontaneously hypertensive rats. , 2020, Acta histochemica.

[26]  Fentanyl , 2019, Reactions Weekly.

[27]  Lin Lu,et al.  The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies , 2019, Translational Psychiatry.

[28]  A. Vanin What is the Mechanism of Nitric Oxide Conversion into Nitrosonium Ions Ensuring S-Nitrosating Processes in Living Organisms , 2019, Cell Biochemistry and Biophysics.

[29]  A. Janowsky,et al.  Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[30]  Jun Guo,et al.  Blockade of the Human Ether A-Go-Go–Related Gene (hERG) Potassium Channel by Fentanyl , 2019, Molecular Pharmacology.

[31]  J. Stamler,et al.  Protein S-Nitrosylation: Determinants of Specificity and Enzymatic Regulation of S-Nitrosothiol-Based Signaling. , 2018, Antioxidants & redox signaling.

[32]  C. Stein New concepts in opioid analgesia , 2018, Expert opinion on investigational drugs.

[33]  L. Teppema,et al.  Bilateral carotid sinus nerve transection exacerbates morphine‐induced respiratory depression , 2018, European journal of pharmacology.

[34]  M. Mehanna,et al.  Antinociceptive effect of tadalafil in various pain models: Involvement of opioid receptors and nitric oxide cyclic GMP pathway , 2018, Toxicology and applied pharmacology.

[35]  A. Dahan,et al.  Averting Opioid-induced Respiratory Depression without Affecting Analgesia. , 2018, Anesthesiology.

[36]  M. Carraway,et al.  RhoA inactivation by S-nitrosylation regulates vascular smooth muscle contractive signaling. , 2018, Nitric oxide : biology and chemistry.

[37]  Maree T. Smith,et al.  Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression , 2018, Neuropharmacology.

[38]  Jill Barr-Walker,et al.  Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review , 2017, Neuropharmacology.

[39]  B. Gaston,et al.  Detection of trace concentrations of S-nitrosothiols by means of a capacitive sensor , 2017, PloS one.

[40]  M. Grégoire,et al.  Opioids for cancer-related pain in children and adolescents. , 2017, The Cochrane database of systematic reviews.

[41]  F. Chung,et al.  Opioids, respiratory depression, and sleep-disordered breathing. , 2017, Best practice & research. Clinical anaesthesiology.

[42]  A. Mori,et al.  Stimulation of &mgr;‐opioid receptors dilates retinal arterioles by neuronal nitric oxide synthase‐derived nitric oxide in rats , 2017, European journal of pharmacology.

[43]  Brian C. Smith,et al.  Nitrosothiol formation and S-nitrosation signaling through nitric oxide synthases. , 2017, Nitric oxide : biology and chemistry.

[44]  Joji Suzuki,et al.  A review: Fentanyl and non-pharmaceutical fentanyls. , 2017, Drug and alcohol dependence.

[45]  W. Varanda,et al.  Nitric Oxide Modulates HCN Channels in Magnocellular Neurons of the Supraoptic Nucleus of Rats by an S-Nitrosylation-Dependent Mechanism , 2016, The Journal of Neuroscience.

[46]  E. Murphy,et al.  Characterization of the sex-dependent myocardial S-nitrosothiol proteome. , 2016, American journal of physiology. Heart and circulatory physiology.

[47]  M. Terry,et al.  Local and systemic vasodilatory effects of low molecular weight S-nitrosothiols. , 2016, Free radical biology & medicine.

[48]  S. Lipton,et al.  Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases. , 2016, Trends in pharmacological sciences.

[49]  R. Wise,et al.  Imaging the Respiratory Effects of Opioids in the Human Brain. , 2016, Advances in experimental medicine and biology.

[50]  J. Vigh,et al.  Light‐evoked S‐nitrosylation in the retina , 2015, The Journal of comparative neurology.

[51]  K. Sharp,et al.  Regulation of brain glutamate metabolism by nitric oxide and S-nitrosylation , 2015, Science Signaling.

[52]  B. Gaston,et al.  Nitrogen chemistry and lung physiology. , 2015, Annual review of physiology.

[53]  Vinod Jyothikumar,et al.  Hypoxia-induced changes in protein s-nitrosylation in female mouse brainstem. , 2015, American journal of respiratory cell and molecular biology.

[54]  A. Tarasenko THE EFFECT OF NITRIC OXIDE ON SYNAPTIC VESICLE PROTON GRADIENT AND MITOCHONDRIAL POTENTIAL OF BRAIN NERVE TERMINALS. , 2015, Ukrainian biochemical journal.

[55]  A. Hausladen,et al.  Identification of S-nitroso-CoA reductases that regulate protein S-nitrosylation , 2014, Proceedings of the National Academy of Sciences.

[56]  K. Strohl,et al.  Enhanced non-eupneic breathing following hypoxic, hypercapnic or hypoxic–hypercapnic gas challenges in conscious mice , 2014, Respiratory Physiology & Neurobiology.

[57]  G. Schwarz,et al.  Neuronal Nitric Oxide Synthase-Dependent S-Nitrosylation of Gephyrin Regulates Gephyrin Clustering at GABAergic Synapses , 2014, The Journal of Neuroscience.

[58]  B. Gaston,et al.  Essential role of hemoglobin beta-93-cysteine in posthypoxia facilitation of breathing in conscious mice. , 2014, Journal of applied physiology.

[59]  Ye Zhang,et al.  Spinal neuronal NOS activation mediates intrathecal fentanyl preconditioning induced remote cardioprotection in rats. , 2014, International immunopharmacology.

[60]  S. Lewis,et al.  Role of central and peripheral opiate receptors in the effects of fentanyl on analgesia, ventilation and arterial blood-gas chemistry in conscious rats , 2014, Respiratory Physiology & Neurobiology.

[61]  A. Altun,et al.  Soluble guanylyl cyclase activators increase the expression of tolerance to morphine analgesic effect. , 2014, Bratislavske lekarske listy.

[62]  J. Gaertner,et al.  Fentanyl for the relief of refractory breathlessness: a systematic review. , 2013, Journal of pain and symptom management.

[63]  S. Lewis,et al.  Morphine has latent deleterious effects on the ventilatory responses to a hypoxic challenge. , 2013, Open journal of molecular and integrative physiology.

[64]  P. Hernansanz-Agustín,et al.  Specificity in S-nitrosylation: a short-range mechanism for NO signaling? , 2013, Antioxidants & redox signaling.

[65]  S. Lewis,et al.  Morphine has latent deleterious effects on the ventilatory responses to a hypoxic-hypercapnic challenge. , 2013, Open journal of molecular and integrative physiology.

[66]  B. Gaston,et al.  Low-dose morphine elicits ventilatory excitant and depressant responses in conscious rats: Role of peripheral μ-opioid receptors. , 2013, Open journal of molecular and integrative physiology.

[67]  S. Todorovic,et al.  Redox Mechanism of S-Nitrosothiol Modulation of Neuronal CaV3.2 T-Type Calcium Channels , 2013, Molecular Neurobiology.

[68]  J. Garzón,et al.  Nitric Oxide and Zinc-Mediated Protein Assemblies Involved in Mu Opioid Receptor Signaling , 2013, Molecular Neurobiology.

[69]  S. Lewis,et al.  Co-activation of μ- and δ-opioid receptors elicits tolerance to morphine-induced ventilatory depression via generation of peroxynitrite , 2013, Respiratory Physiology & Neurobiology.

[70]  B. Gaston,et al.  Ventilatory responses during and following exposure to a hypoxic challenge in conscious mice deficient or null in S-nitrosoglutathione reductase , 2013, Respiratory Physiology & Neurobiology.

[71]  B. Gaston,et al.  Hypoxia-induced ventilatory responses in conscious mice: Gender differences in ventilatory roll-off and facilitation , 2013, Respiratory Physiology & Neurobiology.

[72]  Saptarsi M. Haldar,et al.  S-nitrosylation: integrator of cardiovascular performance and oxygen delivery. , 2013, The Journal of clinical investigation.

[73]  Fadi Xu,et al.  Activation of opioid μ-receptors, but not δ- or κ-receptors, switches pulmonary C-fiber-mediated rapid shallow breathing into an apnea in anesthetized rats , 2012, Respiratory Physiology & Neurobiology.

[74]  Fadi Xu,et al.  Contribution of central μ-receptors to switching pulmonary C-fibers-mediated rapid shallow breathing into an apnea by fentanyl in anesthetized rats , 2012, Brain Research.

[75]  Fadi Xu,et al.  8-OH-DPAT abolishes the pulmonary C-fiber-mediated apneic response to fentanyl largely via acting on 5HT1A receptors in the nucleus tractus solitarius. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[76]  B. Gaston,et al.  S-Nitrosylation signaling regulates cellular protein interactions. , 2012, Biochimica et biophysica acta.

[77]  C. Piantadosi Regulation of mitochondrial processes by protein S-nitrosylation. , 2012, Biochimica et biophysica acta.

[78]  O. Mathiesen,et al.  Intranasal fentanyl in the treatment of acute pain – a systematic review , 2012, Acta anaesthesiologica Scandinavica.

[79]  V. Gutierrez,et al.  Pain and analgesia: The dual effect of nitric oxide in the nociceptive system. , 2011, Nitric oxide : biology and chemistry.

[80]  Mary L McHugh,et al.  Multiple comparison analysis testing in ANOVA. , 2011, Biochemia medica.

[81]  Y. Iwakiri S-nitrosylation of proteins: a new insight into endothelial cell function regulated by eNOS-derived NO. , 2011, Nitric oxide : biology and chemistry.

[82]  Fadi Xu,et al.  Activation of Opioid &mgr;-Receptors in the Commissural Subdivision of the Nucleus Tractus Solitarius Abolishes the Ventilatory Response to Hypoxia in Anesthetized Rats , 2011, Anesthesiology.

[83]  S. Lipton,et al.  On–off system for PI3-kinase–Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN) , 2011, Proceedings of the National Academy of Sciences.

[84]  I. Wittig,et al.  SNO-ing at the Nociceptive Synapse? , 2011, Pharmacological Reviews.

[85]  P. Tsai,et al.  L-type calcium channels and μ-opioid receptors are involved in mediating the anti-inflammatory effects of naloxone. , 2011, The Journal of surgical research.

[86]  J. Holty,et al.  Opioids, sleep, and sleep-disordered breathing. , 2011, Current pharmaceutical design.

[87]  M. Hosseini,et al.  Different responses of nitric oxide synthase inhibition on morphine-induced antinociception in male and female rats. , 2011, Pathophysiology : the official journal of the International Society for Pathophysiology.

[88]  J. Stamler,et al.  The SNO-proteome: causation and classifications. , 2011, Current opinion in chemical biology.

[89]  A. Altun,et al.  The nitric oxide-cGMP signaling pathway plays a significant role in tolerance to the analgesic effect of morphine. , 2011, Canadian journal of physiology and pharmacology.

[90]  T. Savidge,et al.  S-Nitrosothiol Signals in the Enteric Nervous System: Lessons Learnt from Big Brother , 2011, Front. Neurosci..

[91]  O. Pol,et al.  Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling , 2011, Molecular pain.

[92]  L. Palmer,et al.  Gender Differences in S-Nitrosoglutathione Reductase Activity in the Lung , 2010, PloS one.

[93]  Katarzyna A. Broniowska,et al.  Differential mechanisms of inhibition of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosothiols and NO in cellular and cell-free conditions. , 2010, American journal of physiology. Heart and circulatory physiology.

[94]  Vasiliy Sim,et al.  Long-lasting inhibition of presynaptic metabolism and neurotransmitter release by protein S-nitrosylation. , 2010, Free radical biology & medicine.

[95]  J. Stamler,et al.  S-Nitrosylation in Cardiovascular Signaling , 2010, Circulation research.

[96]  M. Teixeira,et al.  Morphine peripheral analgesia depends on activation of the PI3Kγ/AKT/nNOS/NO/KATP signaling pathway , 2010, Proceedings of the National Academy of Sciences.

[97]  A. Dahan,et al.  Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression , 2010, Anesthesiology.

[98]  H. Toda,et al.  Interactions between morphine and nitric oxide in various organs , 2009, Journal of Anesthesia.

[99]  Fadi Xu,et al.  Opioid μ-receptors in medullary raphe region affect the hypoxic ventilation in anesthetized rats , 2009, Respiratory Physiology & Neurobiology.

[100]  J. Stamler,et al.  Protein S-nitrosylation in health and disease: a current perspective. , 2009, Trends in molecular medicine.

[101]  J. Stamler,et al.  S-Nitrosylation of Cardiac Ion Channels , 2009, Journal of cardiovascular pharmacology.

[102]  A. Danser,et al.  Light-induced vs. bradykinin-induced relaxation of coronary arteries: do S-nitrosothiols act as endothelium-derived hyperpolarizing factors? , 2009, Journal of hypertension.

[103]  Jun Ren,et al.  Ampakine CX717 Protects against Fentanyl-induced Respiratory Depression and Lethal Apnea in Rats , 2009, Anesthesiology.

[104]  R. Horner,et al.  Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo , 2009, The Journal of physiology.

[105]  Leonardo Nogueira,et al.  Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture , 2009, Nature Biotechnology.

[106]  O. Pol,et al.  Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain. , 2009, European journal of pharmacology.

[107]  H. Toda,et al.  Modulation of Opioid Actions by Nitric Oxide Signaling , 2009, Anesthesiology.

[108]  P. Lalley Opioidergic and dopaminergic modulation of respiration , 2008, Respiratory Physiology & Neurobiology.

[109]  K. Pattinson,et al.  Opioids and the control of respiration. , 2008, British journal of anaesthesia.

[110]  S. Lewis,et al.  Flavin Adenine Dinucleotide May Release Preformed Stores of Nitrosyl Factors From the Vascular Endothelium of Conscious Rats , 2007, Journal of cardiovascular pharmacology.

[111]  Fadi Xu,et al.  Activation of Opioid &mgr; Receptors in Caudal Medullary Raphe Region Inhibits the Ventilatory Response to Hypercapnia in Anesthetized Rats , 2007, Anesthesiology.

[112]  Matthew W. Foster,et al.  Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2 , 2007, Cell.

[113]  Sheng Li,et al.  Functional characterization of two S-nitroso-L-cysteine transporters, which mediate movement of NO equivalents into vascular cells. , 2007, American journal of physiology. Cell physiology.

[114]  B. Gaston,et al.  Functional regulation of T-type calcium channels by s-nitrosothiols in the rat thalamus. , 2007, Journal of neurophysiology.

[115]  R. Liddington,et al.  Hypoxia Enhances S-Nitrosylation-Mediated NMDA Receptor Inhibition via a Thiol Oxygen Sensor Motif , 2007, Neuron.

[116]  O. Pol The involvement of the nitric oxide in the effects and expression of opioid receptors during peripheral inflammation. , 2007, Current medicinal chemistry.

[117]  M. Mattson,et al.  Class II G protein-coupled receptors and their ligands in neuronal function and protection , 2007, NeuroMolecular Medicine.

[118]  A. Fields,et al.  Analysis of the Effects of Fentanyl in the Feline Pulmonary Vascular Bed , 2006, American journal of therapeutics.

[119]  A. Iskit,et al.  The effect of nitric oxide on fentanyl and haloperidol‐induced catalepsy in mice* , 2006, European journal of anaesthesiology.

[120]  Allan Doctor,et al.  S-nitrosothiol signaling in respiratory biology. , 2006, American journal of respiratory and critical care medicine.

[121]  S. Lewis,et al.  The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats. , 2006, Vascular pharmacology.

[122]  S. Lewis,et al.  ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats. , 2006, Vascular pharmacology.

[123]  E. Whalen,et al.  Downregulation of propranolol‐sensitive β‐adrenoceptor signaling after inhibition of nitric oxide synthesis , 2006, British journal of pharmacology.

[124]  S. Nadtochiy,et al.  Direct evidence for S-nitrosation of mitochondrial complex I. , 2006, The Biochemical journal.

[125]  A. Johnson,et al.  Role of nitrosyl factors in the hindlimb vasodilation elicited by baroreceptor afferent nerve stimulation. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[126]  S. Lewis,et al.  S-nitrosocysteine elicits hemodynamic responses similar to those of the Bezold-Jarisch reflex via activation of stereoselective recognition sites. , 2006, European journal of pharmacology.

[127]  J. Miller,et al.  Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide. , 2006, Life sciences.

[128]  Claude A Piantadosi,et al.  S-nitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[129]  S. Lewis,et al.  Vasodilator actions of the endothelium‐derived relaxing factor l‐S‐nitrosocysteine in anaesthetized rats are markedly diminished by peroxynitrite , 2005, Clinical and experimental pharmacology & physiology.

[130]  S. Lewis,et al.  Peroxynitrite Elicits Dysfunction of Stereoselective S-Nitrosocysteine Recognition Sites , 2005, Journal of cardiovascular pharmacology.

[131]  S. Lewis,et al.  Differentiation of L- and D-S-Nitrosothiol Recognition Sites In Vivo , 2005, Journal of cardiovascular pharmacology.

[132]  S. Lewis,et al.  Endogenous nitrosyl factors may inhibit the desensitization of 5-HT3 receptors on vagal cardiopulmonary afferents , 2005, Brain Research.

[133]  T. Şahin,et al.  The mechanisms of the direct vascular effects of fentanyl on isolated human saphenous veins in vitro. , 2005, Journal of cardiothoracic and vascular anesthesia.

[134]  P. Moorehead Dyspnea , 1962, Canadian Medical Association Journal.

[135]  J. Stamler,et al.  Role of circulating S-nitrosothiols in control of blood pressure. , 2005, Hypertension.

[136]  T. Kokkola,et al.  S-Nitrosothiols modulate G protein-coupled receptor signaling in a reversible and highly receptor-specific manner , 2005, BMC Cell Biology.

[137]  G. Citro,et al.  Morphine but not fentanyl and methadone affects mitochondrial membrane potential by inducing nitric oxide release in glioma cells , 2004, Cellular and Molecular Life Sciences CMLS.

[138]  P. Saxena,et al.  L-S-Nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries? , 2004, Journal of hypertension.

[139]  V. V. Shorin,et al.  No-Ergic Neurons of the Cervical Nucleus of the Rat Brain in Normal Conditions and After Administration of Opiates , 2004, Neuroscience and Behavioral Physiology.

[140]  N. Mitagvariya,et al.  The Effects of Fentanyl and Morphine on Local Blood Flow and Oxygen Tension in the Frontoparietal Cortex and Nucleus Accumbens of the Brain in White Rats , 2004, Neuroscience and Behavioral Physiology.

[141]  Xin Wang,et al.  Fentanyl inhibits GABAergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus , 2004, Brain Research.

[142]  I. Fleming,et al.  Bradykinin‐induced relaxation of coronary microarteries: S‐nitrosothiols as EDHF? , 2004, British journal of pharmacology.

[143]  H. E. Marshall,et al.  Essential Roles of S-Nitrosothiols in Vascular Homeostasis and Endotoxic Shock , 2004, Cell.

[144]  V. V. Shorin,et al.  Dynamics of NADPH Diaphorase Activity in Raphe Neurons during Chronic Treatment with Opiates , 2001, Bulletin of Experimental Biology and Medicine.

[145]  M. Laubie,et al.  Central sites and mechanisms of the hypotensive and bradycardic effects of the narcotic analgesic agent fentanyl , 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.

[146]  C. R. Tonussi,et al.  The L-arginine/nitric oxide/cyclic-GMP pathway apparently mediates the peripheral antihyperalgesic action of fentanyl in rats. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[147]  Limin Liu,et al.  Screening for Nitric Oxide-Dependent Protein-Protein Interactions , 2003, Science.

[148]  B. Gaston,et al.  S-nitrosylation signaling in cell biology. , 2003, Molecular interventions.

[149]  P. Lalley Mu-opioid receptor agonist effects on medullary respiratory neurons in the cat: evidence for involvement in certain types of ventilatory disturbances. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[150]  Robert L. Mason,et al.  Statistical Principles in Experimental Design , 2003 .

[151]  A. Vanin,et al.  Activation of soluble guanylate cyclase by NO donors--S-nitrosothiols, and dinitrosyl-iron complexes with thiol-containing ligands. , 2003, Nitric oxide : biology and chemistry.

[152]  Takeshi Saito,et al.  Involvement of the system L amino acid transporter on uptake of S-nitroso-L-cysteine, an endogenous S-nitrosothiol, in PC12 cells. , 2003, European journal of pharmacology.

[153]  V. V. Shorin,et al.  [NO-ergic rat brain commissural neurons in the norm and during opiate administration]. , 2003, Morfologiia.

[154]  R. Irvine,et al.  Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. , 2002, European journal of pharmacology.

[155]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[156]  D. Gozal,et al.  S-Nitrosothiols signal the ventilatory response to hypoxia , 2001, Nature.

[157]  Paul Tempst,et al.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide , 2001, Nature Cell Biology.

[158]  S. Lewis,et al.  Blockade of voltage-sensitive Ca(2+)-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo. , 2000, European journal of pharmacology.

[159]  S. Lewis,et al.  Apparent association of MK-801-sensitive ion channels with L-S-nitrosocysteine recognition sites in the hindlimb vasculature of the rat. , 2000, European journal of pharmacology.

[160]  S. Lewis,et al.  Redox regulation of S-nitrosocysteine-mediated vasodilation in vivo. , 2000, European journal of pharmacology.

[161]  E. Whalen,et al.  β-Adrenoceptor Dysfunction After Inhibition of NO Synthesis , 2000 .

[162]  J. R. Tobin,et al.  S-nitroso-l-cysteine releases norepinephrine in rat spinal synaptosomes 1 1 Published on the World Wide Web on 20 June 2000. , 2000, Brain Research.

[163]  E. Bradley,et al.  Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems. , 2000 .

[164]  The neuronal nitric oxide synthase inhibitor 7-nitroindazole (7-NI) and morphine act independently on the control of breathing. , 2000, British journal of anaesthesia.

[165]  H. Loh,et al.  Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.

[166]  A. Dahan,et al.  Sex differences in morphine-induced ventilatory depression reside within the peripheral chemoreflex loop. , 2000, Anesthesiology.

[167]  S. Lewis,et al.  In vivo evidence that L-S-nitrosocysteine may exert its vasodilator effects by interaction with thiol residues in the vasculature. , 1999, European journal of pharmacology.

[168]  K. Sakimura,et al.  Direct inhibition of the N-methyl-D-aspartate receptor channel by high concentrations of opioids. , 1999, Anesthesiology.

[169]  Qing-ping Wang,et al.  Electron microscopic observation of μ-opioid receptor in the rat area postrema☆ , 1999, Peptides.

[170]  E. Whalen,et al.  Rapid tachyphylaxis to hemodynamic effects of PACAP-27 after inhibition of nitric oxide synthesis. , 1999, American journal of physiology. Heart and circulatory physiology.

[171]  A. Dahan,et al.  Sex Differences in Morphine-induced Ventilatory Depression Reside within the Peripheral Chemoreflex Loop , 1999 .

[172]  J. Levine,et al.  NOS inhibitor antagonism of PGE2-induced mechanical sensitization of cutaneous C-fiber nociceptors in the rat. , 1999, Journal of neurophysiology.

[173]  J Ludbrook,et al.  MULTIPLE COMPARISON PROCEDURES UPDATED , 1998, Clinical and experimental pharmacology & physiology.

[174]  J. Levine,et al.  Nitric Oxide Signaling in Pain and Nociceptor Sensitization in the Rat , 1998, The Journal of Neuroscience.

[175]  D. Zochodne,et al.  Local nitric oxide synthase activity in a model of neuropathic pain , 1998, The European journal of neuroscience.

[176]  T. Bilfinger,et al.  Morphine's immunoregulatory actions are not shared by fentanyl. , 1998, International journal of cardiology.

[177]  A. Dahan,et al.  Sex‐related Differences in the Influence of Morphine on Ventilatory Control in Humans , 1998, Anesthesiology.

[178]  R. J. Spencer,et al.  Mobilization of Ca2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes. , 1997, Biochemical pharmacology.

[179]  S. Lewis,et al.  Hemodynamic effects of L- and D-S-nitroso-beta,beta-dimethylcysteine in rats. , 1997, The American journal of physiology.

[180]  S. Lewis,et al.  NO-containing factors mediate hindlimb vasodilation produced by superior laryngeal nerve stimulation. , 1997, The American journal of physiology.

[181]  C. Delporte,et al.  The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins. , 1997, Biochimica et biophysica acta.

[182]  I. T. Demchenko,et al.  Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. , 1997, Science.

[183]  A. Dahan,et al.  Influences of Morphine on the Ventilatory Response to Isocapnic Hypoxia , 1997, Anesthesiology.

[184]  S. Lewis,et al.  Neurogenically derived nitrosyl factors mediate sympathetic vasodilation in the hindlimb of the rat. , 1997, The American journal of physiology.

[185]  A. K. Johnson,et al.  Stereoselective actions of S-nitrosocysteine in central nervous system of conscious rats. , 1997, The American journal of physiology.

[186]  W. Talman,et al.  Actions of S-nitrosocysteine in the nucleus tractus solitarii are unrelated to release of nitric oxide , 1997, Brain Research.

[187]  L. Stoll,et al.  l- and d-S-nitroso-β,β-dimethylcysteine differentially increase cGMP in cultured vascular smooth muscle cells , 1996 .

[188]  D. Pelligrino,et al.  Nitric Oxide Synthase Inhibition Modulates the Ventilatory Depressant and Antinociceptive Actions of Fourth Ventricular Infusions of Morphine in the Awake Dog , 1996, Anesthesiology.

[189]  S. Lewis,et al.  Stereoselective S-nitrosocysteine recognition sites in rat brain. , 1996, European journal of pharmacology.

[190]  A. K. Johnson,et al.  Use-dependent loss of active sympathetic neurogenic vasodilation after nitric oxide synthase inhibition in conscious rats. Evidence for the presence of preformed stores of nitric oxide-containing factors. , 1996, Hypertension.

[191]  A. K. Johnson,et al.  Use-dependent loss of acetylcholine- and bradykinin-mediated vasodilation after nitric oxide synthase inhibition. Evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. , 1996, Hypertension.

[192]  K. Fukuda,et al.  Functional Coupling of the δ‐, μ‐, and κ‐Opioid Receptors to Mitogen‐Activated Protein Kinase and Arachidonate Release in Chinese Hamster Ovary Cells , 1996 .

[193]  S. Lewis,et al.  Hemodynamic effects of L- and D-S-nitrosocysteine in the rat. Stereoselective S-nitrosothiol recognition sites. , 1996, Circulation research.

[194]  Xiao-jun Xu,et al.  Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors , 1996, PAIN®.

[195]  A. K. Johnson,et al.  Stimulation of lumbar sympathetic nerves may produce hindlimb vasodilation via the release of pre-formed stores of nitrosyl factors , 1996, Neuroscience.

[196]  M. J. George,et al.  Regulation of calcium-activated potassium channels by S-nitrosothiol compounds and cyclic guanosine monophosphate in rabbit coronary artery myocytes. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[197]  G. Kaczorowski,et al.  Charybdotoxin and its effects on potassium channels. , 1995, The American journal of physiology.

[198]  H. Loh,et al.  Properties of a κ-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual Gα subunit and is similar to that of other opioid receptors , 1995 .

[199]  F. Abboud,et al.  Modulation of baroreceptor activity by nitric oxide and S-nitrosocysteine. , 1995, Circulation research.

[200]  D. Grandy,et al.  Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes. , 1995, Molecular pharmacology.

[201]  A. K. Johnson,et al.  Nitrosyl factors mediate active neurogenic hindquarter vasodilation in the conscious rat. , 1994, Hypertension.

[202]  R. Cohen,et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.

[203]  D. Madison,et al.  NITRIC OXIDE AND , 1994 .

[204]  J. Stamler,et al.  Nitric oxide in the central nervous system. , 1994, Progress in brain research.

[205]  H. Kontos,et al.  Nitric Oxide and S‐Nitroso‐L‐Cysteine as Endothelium‐Derived Relaxing Factors From Acetlcholine in Cerebral Vessels in Cats , 1993, Stroke.

[206]  Joseph Loscalzo,et al.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds , 1993, Nature.

[207]  G. Feuerstein,et al.  Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors? , 1993, The Journal of pharmacology and experimental therapeutics.

[208]  G. Schultz,et al.  μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells , 1993, Neuron.

[209]  G. Schultz,et al.  mu and delta opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. , 1993, Neuron.

[210]  S. Lipton,et al.  Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex , 1992, Neuron.

[211]  H. Loh,et al.  Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells. , 1992, Molecular pharmacology.

[212]  E. Ross,et al.  Selectivity of the beta-adrenergic receptor among Gs, Gi's, and Go: assay using recombinant alpha subunits in reconstituted phospholipid vesicles. , 1991, Biochemistry.

[213]  S. Ferreira,et al.  The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. , 1991, European journal of pharmacology.

[214]  H. Szeto,et al.  Morphine-induced stimulation of fetal breathing: role of mu 1-receptors and central muscarinic pathways. , 1991, The American journal of physiology.

[215]  M. Brody,et al.  Reduced nociceptive effects of intravenous serotonin (5-HT) in the spontaneously hypertensive rat. , 1991, Clinical and experimental hypertension. Part A, Theory and practice.

[216]  D. Harrison,et al.  EDRF: nitrosylated compound or authentic nitric oxide. , 1991, Basic research in cardiology.

[217]  M. Brody,et al.  Is there a role for an endothelium-derived relaxing factor in nociception? , 1990, Brain Research.

[218]  D. Harrison,et al.  Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide , 1990, Nature.

[219]  G. Feuerstein,et al.  Respiratory and locomotor stimulation by low doses of dermorphin, a mu1 receptor-mediated effect. , 1990, The Journal of pharmacology and experimental therapeutics.

[220]  M. Yeadon,et al.  Multiple opioid receptors mediate the respiratory depressant effects of fentanyl-like drugs in the rat. , 1990, General pharmacology.

[221]  M. Zimpfer,et al.  Fentanyl Inhibits the Canine Carotid Chemoreceptor Reflex , 1989, Anesthesia and analgesia.

[222]  M. Caron,et al.  Properties of the beta 1- and beta 2-adrenergic receptor subtypes revealed by molecular cloning. , 1989, Clinical chemistry.

[223]  H. Szeto,et al.  Dual action of morphine on fetal breathing movements. , 1988, The Journal of pharmacology and experimental therapeutics.

[224]  J T Williams,et al.  Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[225]  G. Schultz,et al.  The GTP-binding protein, Go9 regulates neuronal calcium channels , 1987, Nature.

[226]  R. Willette,et al.  Activation of cholinergic mechanisms in the medulla oblongata reverse intravenous opioid-induced respiratory depression. , 1987, The Journal of pharmacology and experimental therapeutics.

[227]  H. Wilson,et al.  The effects of alfentanil and selected narcotic analgesics on the rate of action potential discharge of medullary respiratory neurones in anaesthetized rats , 1986, British journal of pharmacology.

[228]  G. Kirby,et al.  Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo , 1986, British journal of pharmacology.

[229]  A. Faden,et al.  Central effects of μ, δ, and κ receptor agonists in hemorrhagic shock , 1985, Peptides.

[230]  Regulation of ventilation and oxygen consumption by delta- and mu-opioid receptor agonists. , 1985, Journal of applied physiology.

[231]  M. Hurlé,et al.  Differential respiratory patterns induced by opioids applied to the ventral medullary and dorsal pontine surfaces of cats , 1985, Neuropharmacology.

[232]  G. Haddad,et al.  Opposite effects of the δ- and μ-opioid receptor agonists on ventilation in conscious adult dogs , 1984, Brain Research.

[233]  L. Ignarro,et al.  Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. , 1983, Molecular pharmacology.

[234]  M. Zimpfer,et al.  [Effects of morphine on the control of the cardiovascular system by the carotid-sinus-reflex and by the carotid chemoreflex]. , 1983, Der Anaesthesist.

[235]  A. Faden,et al.  μ Receptors and opioid cardiovascular effects in the NTS of rat , 1982, Peptides.

[236]  J. Metcalfe,et al.  Respiratory and hemodynamic effects of methadone in pregnant women. , 1980, Respiration physiology.

[237]  R. A. Epstein,et al.  Practical implementation of the barometric method for measurement of tidal volume. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[238]  J. Fleiss,et al.  Some Statistical Methods Useful in Circulation Research , 1980, Circulation research.

[239]  D. McQueen,et al.  INHIBITORY ACTIONS OF METHIONINE‐ENKEPHALIN AND MORPHINE ON THE CAT CAROTID CHEMORECEPTORS , 1980, British journal of pharmacology.

[240]  R. A. Epstein,et al.  A theoretical analysis of the barometric method for measurement of tidal volume. , 1978, Respiration physiology.

[241]  M. Kuhar,et al.  Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon , 1977, Brain Research.

[242]  M. Nirenberg,et al.  Opiate-dependent modulation of adenylate cyclase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[243]  M. Kuhar,et al.  Autoradiographic localization of opiate receptors in rat brain. II. The brain stem , 1977, Brain Research.